Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Hyperfine, Inc. - Class A Common Stock
(NQ:
HYPR
)
0.9786
+0.0207 (+2.16%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 31, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Hyperfine, Inc. - Class A Common Stock
< Previous
1
2
3
4
5
Next >
Hyperfine, Inc. Receives Grant for an Additional Three Years to Utilize Innovative Swoop® Portable MR Imaging® System in Low and Middle-Income Countries
May 18, 2023
From
Hyperfine, Inc.
Via
Business Wire
Recap: Hyperfine Q1 Earnings
May 11, 2023
Via
Benzinga
Hyperfine, Inc. Reports First Quarter 2023 Financial Results
May 11, 2023
From
Hyperfine, Inc.
Via
GlobeNewswire
Hyperfine, Inc. to Announce First Quarter Financial Results on May 11, 2023
April 20, 2023
From
Hyperfine, Inc.
Via
GlobeNewswire
Hyperfine's Earnings: A Preview
March 20, 2023
Via
Benzinga
Hyperfine, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results
March 21, 2023
From
Hyperfine, Inc.
Via
GlobeNewswire
Earnings Scheduled For March 21, 2023
March 21, 2023
Companies Reporting Before The Bell • LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.20 per share on revenue of $41.75 million.
Via
Benzinga
Why Provention Bio Shares Are Trading Higher By Over 260%; Here Are 20 Stocks Moving Premarket
March 13, 2023
Gainers Provention Bio, Inc. (NASDAQ: PRVB) rose 262.7% to $24.30 in pre-market trading after Sanofi agreed to acquire the company for $25.00 per share in cash, representing an equity value of...
Via
Benzinga
Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2022 Financial Results on March 21, 2023
March 06, 2023
From
Hyperfine, Inc.
Via
GlobeNewswire
Hyperfine, Inc. Receives FDA Clearance for Updated Software to Further Improve Diffusion-Weighted Imaging
February 28, 2023
Swoop® Portable MR Imaging® system positioned to offer even greater clinical utility in neurocritical care
From
Hyperfine, Inc.
Via
GlobeNewswire
Hyperfine, Inc. Swoop® Portable MR Imaging® System Receives CE Marking After Meeting Comprehensive New EU MDR Regulations
February 21, 2023
CE Marking for the company’s portable MRI system with AI-powered imaging software demonstrates that the system complies with safety and performance requirements in the EU and provides the company...
From
Hyperfine, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 16, 2023
Via
Benzinga
Why Top Ships Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 14, 2023
Gainers Amesite Inc. (NASDAQ: AMST) shares jumped 123% to $0.6284 after the company announced GPT-3 powered functionality to its AI toolkit for customers and users.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 14, 2023
Via
Benzinga
Hyperfine, Inc. Announces FDA Clearance for Improved AI-Powered Software and Expanded Field of View for the Swoop® Portable MR Imaging® System
February 13, 2023
Latest Swoop® software improves image quality for DWI imaging of the brain
From
Hyperfine, Inc.
Via
GlobeNewswire
Latest Data Demonstrate Potential of the Swoop® Portable MR Imaging® System in the Follow-up of Stroke Patients Who Have Received a Thrombectomy
February 09, 2023
New study utilizes Hyperfine, Inc. portable MRI system in monitoring brain injury and evaluating physiological impacts
From
Hyperfine, Inc.
Via
GlobeNewswire
Hyperfine, Inc. Announces Brett Hale as New Chief Administrative Officer & Chief Financial Officer
February 08, 2023
From
Hyperfine, Inc.
Via
GlobeNewswire
Hyperfine Swoop® Point-of-Care MRI System™ Takes the Stage at ISMRM with Twelve Abstract Inclusions
February 06, 2023
Research highlights the significance and clinical relevance of portable MRI technology
From
Hyperfine, Inc.
Via
GlobeNewswire
Why AppTech Payments Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 31, 2023
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 31, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 19, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
December 20, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
December 13, 2022
Via
Benzinga
Why Quotient Shares Are Trading Lower By More Than 48%; Here Are 37 Stocks Moving Premarket
December 13, 2022
Gainers Netcapital Inc. (NASDAQ: NCPL) shares rose 91.3% to $2.65 in pre-market trading following Q2 results. Netcapital posted Q2 earnings of $0.04 per share on sales of $1.78 million.
Via
Benzinga
Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
December 13, 2022
Gainers OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 23, 2022
Via
Benzinga
Hyperfine to Present at the 5th Annual Evercore ISI HealthCONx Conference
November 22, 2022
From
Hyperfine, Inc.
Via
GlobeNewswire
Hyperfine Reports Third Quarter 2022 Financial Results
November 10, 2022
From
Hyperfine, Inc.
Via
GlobeNewswire
Why Global Payments Shares Are Trading Lower By Around 8%? Here Are 41 Stocks Moving In Monday's Mid-Day Session
October 31, 2022
Gainers 1847 Holdings LLC (NASDAQ: EFSH) shares surged 72.7% to $3.25 after the company reported it sees over $60 million in revenue and over $7 million in cash flow from operations in 2023 from its...
Via
Benzinga
Hyperfine to Announce Third Quarter 2022 Financial Results on November 10, 2022
October 27, 2022
From
Hyperfine, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.